Figure 2
Figure 2. Decreased expression of ISGs in APECED cell populations. Expression of ISGs (A) and other genes (E) in freshly isolated PBMCs from IFN-α antibody-positive (Ab+, 4 cases) and -negative (Ab−, 1 case) APECED patients and healthy controls (Ctrl, 5 cases). (C) Expression of ISGs in freshly isolated plasmacytoid DCs (2 cases in each group). (B) Expression of ISGs in freshly isolated monocytes from IFN-α antibody-positive (6 cases) and -negative (1 case) APECED patients and healthy controls (7 cases). (D) Expression of ISGs in monocyte-derived DCs from APECED patients and healthy controls (3 cases in each group). *P < .05, **P < .001, ***P < .001, comparison of the Ab+ APECED patient and control blood cells. Bars represent group averages.

Decreased expression of ISGs in APECED cell populations. Expression of ISGs (A) and other genes (E) in freshly isolated PBMCs from IFN-α antibody-positive (Ab+, 4 cases) and -negative (Ab, 1 case) APECED patients and healthy controls (Ctrl, 5 cases). (C) Expression of ISGs in freshly isolated plasmacytoid DCs (2 cases in each group). (B) Expression of ISGs in freshly isolated monocytes from IFN-α antibody-positive (6 cases) and -negative (1 case) APECED patients and healthy controls (7 cases). (D) Expression of ISGs in monocyte-derived DCs from APECED patients and healthy controls (3 cases in each group). *P < .05, **P < .001, ***P < .001, comparison of the Ab+ APECED patient and control blood cells. Bars represent group averages.

Close Modal

or Create an Account

Close Modal
Close Modal